T1	intervention 0 31	Menopausal hormone therapy (HT)
T2	outcome 1056 1107	chance of reoccurrence and cancer-related mortality
T5	outcome 874 898	Cancer-related mortality
T6	iv-bin-percent 921 925	2.6%
T7	outcome 952 969	overall mortality
T8	iv-bin-percent 974 978	4.5%
T9	outcome 821 833	reoccurrence
T10	iv-bin-percent 847 852	10.0%
T11	control-participants 781 785	1998
T12	intervention-participants 674 678	1416
T14	control 754 767	control group
T15	outcome 1293 1312	cancer reoccurrence
T16	outcome 1314 1357	cancer-related mortality or total mortality
